KDM7A and breast carcinoma: Employing the KM-plotter on breast cancer datasets (see Methods, Supplementary Information), we calculate ‘the best’ (optimized) cut-off value for the KDM7A-DT expression levels to discriminate the relatively low- and high-risk outcome groups.